OPTIMAL CONDITIONS FOR SYNTHESIS OF LONG COMPLEMENTARY DNA PRODUCT WITH MOLONEY MURINE LEUKEMIA VIRUSVAN BEVEREN C; GOULIAN M.1979; J. VIROL.; USA; DA. 1979; VOL. 30; NO 3; PP. 951-954; BIBL. 18 REF.Article

DETECTION OF SEQUENCES IN HUMAN LEUKEMIC CELL DNA HOMOLOGOUS WITH MOLONEY MOUSE LEUKEMIA VIRAL RNAVAN BEVEREN C; GOULIAN M.1979; CANCER. RES.; USA; DA. 1979; VOL. 39; NO 7 PART. 1; PP. 2532-2537; BIBL. 45 REF.Article

IDENTIFICATION OF A RNA POLYMERASE II INITIATION SITE IN THE LONG TERMINAL REPEAT OF MOLONEY MURINE LEUKEMIA VIRAL DNAFUHRMAN SA; VAN BEVEREN C; VERMA IM et al.1981; PROC. NATL. ACAD. SCI. U.S.A., BIOL. SCI.; ISSN 0273-1134; USA; DA. 1981; VOL. 78; NO 9; PP. 5411-5415; BIBL. 41 REF.Article

NUCLEOTIDE SEQUENCE OF THE GENOME OF A MURINE SARCOMA VIRUSVAN BEVEREN C; VAN STRAATEN F; GALLESHAW JA et al.1981; CELL (CAMB.); ISSN 0092-8674; USA; DA. 1981; VOL. 27; NO 1; PP. 97-108; BIBL. 2 P.Article

LONG TERMINAL REPEAT OF MURINE RETROVIRAL DNAS: SEQUENCE ANALYSIS, HOST-PROVIRAL JUNCTIONS, AND PREINTEGRATION SITE = LA LONGUE REPETITION TERMINALE DES ADN RETROVIRAUX MURINS: ANALYSE DE SEQUENCE, JONCTIONS HOTE-PROVIRUS, SITE DE PREINTEGRATIONVAN BEVEREN C; RANDS E; CHATTOPADHYAY SK et al.1982; J. VIROL.; ISSN 0022-538X; USA; DA. 1982; VOL. 41; NO 2; PP. 542-556; BIBL. 44 REF.Article

NUCLEOTIDE SEQUENCE OF THE GENOME OF A MURINE SARCOMA VIRUS = SEQUENCE NUCLEOTIDIQUE DU GENOME D'UN VIRUS DE SARCOME MURINVAN BEVEREN C; VAN STRAATEN F; GALLESHAW JA et al.1981; CELL (CAMB.); ISSN 0092-8674; USA; DA. 1981; VOL. 27; NO 1; PP. 97-108; BIBL. 2 P.Article

STRUCTURE OF MOLONEY MURINE LEUKEMIA VIRAL DNA: NUCLEOTIDE SEQUENCE OF THE 5' LONG TERMINAL REPEAT AND ADJACENT CELLULAR SEQUENCESVAN BEVEREN C; GODDARD JG; BERNS A et al.1980; PROC. NATL. ACAD. SCI. U.S.A., BIOL. SCI.; USA; DA. 1980; VOL. 77; NO 6; PP. 3307-3311; BIBL. 40 REF.Article

Homology among oncogenesVAN BEVEREN, C; VERMA, I. M.Current Topics in Microbiology and Immunology. 1986, Vol 123, pp 73-98, issn 0070-217XArticle

COMPLETE NUCLEOTIDE SEQUENCE OF A HUMAN C-ONC GENE: DEDUCED AMINO ACID SEQUENCE OF THE HUMAN C-FOS PROTEINVAN STRAATEN F; MUELLER R; CURRAN T et al.1983; PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. BIOLOGICAL SCIENCES; ISSN 0273-1134; USA; DA. 1983; VOL. 80; NO 11; PP. 3183-3187; BIBL. 38 REF.Article

ANALYSIS OF THE ENV GENE OF A MOLECULARY CLONED AND BIOLOGICALLY ACTIVE MOLONEY MINK CELL FOCUS-FORMING PROVIRAL DNA = ANALYSE D'UN GENE ENV, PROVENANT D'UN ADN PROVIRAL DU VIRUS DE MOLONEY FORMANT DES FOYERS SUR LES CELLULES DE VISON, CLONE ET BIOLOGIQUEMENT ACTIFROSSELMAN RA; VAN STRAATEN F; VAN BEVEREN C et al.1982; J. VIROL.; ISSN 0022-538X; USA; DA. 1982; VOL. 44; NO 1; PP. 19-31; BIBL. 2 P.Article

NUCLEOTIDE SEQUENCE AND FORMATION OF THE TRANSFORMING GENE OF A MOUSE SARCOMA VIRUSVAN BEVEREN C; GALLESHAW JA; JONAS V et al.1981; NATURE (LOND.); ISSN 0028-0836; GBR; DA. 1981; VOL. 289; NO 5795; PP. 258-262; BIBL. 43 REF.Article

Viral and cellular fos proteins are complexed with a 39,000-dalton cellular proteinCURRAN, T; VAN BEVEREN, C; LING, N et al.Molecular and cellular biology (Print). 1985, Vol 5, Num 1, pp 167-172, issn 0270-7306Article

FBR murine osteosarcoma virus. II: Nucleotide sequence of the provirus reveals that the genome contains sequences acquired from two cellular genes = Virus de l'ostéosarcome murin FBR. II. La séquence nucléotidique du provirus révèle que le génome contient des séquences acquises à partir de deux gènes cellulairesVAN BEVEREN, C; ENAMI, S; CURRAN, T et al.Virology (New York, NY). 1984, Vol 135, Num 1, pp 229-243, issn 0042-6822Article

The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogeneKLEMSZ, M. J; MCKERCHER, S. R; CELADA, A et al.Cell (Cambridge). 1990, Vol 61, Num 1, pp 113-124, issn 0092-8674Article

The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinasesSELTEN, G; CUYPERS, H. T; BOELENS, W et al.Cell (Cambridge). 1986, Vol 46, Num 4, pp 603-611, issn 0092-8674Article

Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminusCOUSSENS, L; VAN BEVEREN, C; SMITH, D et al.Nature (London). 1986, Vol 320, Num 6059, pp 277-280, issn 0028-0836Article

Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activationPONGUBALA, J. M. R; VAN BEVEREN, C; NAGULAPALLI, S et al.Science (Washington, D.C.). 1993, Vol 259, Num 5101, pp 1622-1625, issn 0036-8075Article

Construction and characterization of retroviral vectors for interleukin-2 gene therapyFAKHRAI, H; SHAWLER, D. L; GOLD, D. P et al.Journal of immunotherapy with emphasis on tumor immunology. 1997, Vol 20, Num 6, pp 437-448, issn 1067-5582Article

Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts : A phase I studySOBOL, R. E; SHAWLER, D. L; BROSTOFF, S et al.Clinical cancer research. 1999, Vol 5, Num 9, pp 2359-2365, issn 1078-0432Article

Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccineSHAWLER, D. L; BARTHOLOMEW, R. M; SHERMAN, L. A et al.Clinical and experimental immunology (Print). 2002, Vol 129, Num 1, pp 99-106, issn 0009-9104Article